JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB137539

Anti-PLK2 antibody

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Polyclonal PLK2 antibody. Suitable for WB, IHC-P and reacts with Human, Mouse samples. Cited in 5 publications. Immunogen corresponding to Recombinant Fragment Protein within Human PLK2 aa 350 to C-terminus.

View Alternative Names

SNK, PLK2, Serine/threonine-protein kinase PLK2, Polo-like kinase 2, Serine/threonine-protein kinase SNK, Serum-inducible kinase, PLK-2, hPlk2, hSNK

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PLK2 antibody (AB137539)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PLK2 antibody (AB137539)

Immunohistochemical analysis paraffin-embedded mouse colon tissue staining PLK2 protein at cytosol with ab137539 at 1/500 dilution.
Antigen Retrieval : EDTA based buffer, pH 8.0, 15min.

Western blot - Anti-PLK2 antibody (AB137539)
  • WB

Unknown

Western blot - Anti-PLK2 antibody (AB137539)

7.5% SDS PAGE

All lanes:

Western blot - Anti-PLK2 antibody (ab137539) at 1/1000 dilution

All lanes:

A549 (human lung carcinoma cell line) whole cell lysate at 30 µg

Secondary

All lanes:

HRP-conjugated anti-rabbit IgG antibody

Predicted band size: 68 kDa,78 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

IHC-P, WB

applications

Immunogen

Recombinant Fragment Protein within Human PLK2 aa 350 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q9NYY3

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CPAP, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling : required for overactivity-dependent spine remodeling by phosphorylating the Ras activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their degradation by the proteasome. Conversely, phosphorylates the Rap activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their activity. Also regulates synaptic plasticity independently of kinase activity, via its interaction with NSF that disrupts the interaction between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown of AMPAR-mediated current that occludes long term depression. Required for procentriole formation and centriole duplication by phosphorylating CPAP and NPM1, respectively. Its induction by p53/TP53 suggests that it may participate in the mitotic checkpoint following stress.
See full target information PLK2

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

FEBS open bio 15:856-866 PubMed39927502

2025

A potential tumor suppressor role of PLK2 in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangping Xia,Peirui Wang,Hua Xiao,Qishan Ran,Yan Li,Shengtao Yao

Biochemistry and biophysics reports 30:101247 PubMed35300109

2022

Natural COA water inhibits mitochondrial ROS-mediated apoptosis through Plk3 downregulation under STZ diabetic stress in pancreatic β-cell lines.

Applications

Unspecified application

Species

Unspecified reactive species

Jeyeon Lee,Jin Ook Chung,Seon-Young Park,Naveen Rajamohan,Aparna Singh,JungJin Kim,Val J Lowe,SeungBaek Lee

Bioengineered 12:2022-2032 PubMed34060415

2021

Circular RNA 0102049 suppresses the progression of osteosarcoma through modulating miR-520g-3p/PLK2 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xianliao Zhang,Zhengbo Hu,Wenhu Li,Zhongxun Liu,Jie Li,Zhaozhen Wang,Vidmi Taolam Martin,Bing Yan,Bo Yu

Viruses 12: PubMed32231136

2020

Proteome Analysis in a Mammalian Cell line Reveals that PLK2 is Involved in Avian Metapneumovirus Type C (aMPV/C)-Induced Apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Quan,Li Wei,Lei Hou,Jing Wang,Shanshan Zhu,Zixuan Li,Moran Lv,Jue Liu

International journal of oncology 52:1401-1414 PubMed29568868

2018

Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yuquan Xie,Ying Liu,Qiubo Li,Jianming Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com